Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

cardinal health inc. - CAH

CAH

Close Chg Chg %
122.45 0.90 0.73%

Open Market

123.35

+0.90 (0.73%)

Volume: 567.40K

Last Updated:

Dec 3, 2024, 2:38 PM EDT

Trade Now

Company Overview: cardinal health inc. - CAH

CAH Key Data

Open

$123.18

 Day Range

122.15 - 123.54

52 Week Range

93.17 - 126.14

 Market Cap

$29.64B

Shares Outstanding

242.01M

 Public Float

241.33M

Beta

0.63

 Rev. Per Employee

N/A

P/E Ratio

23.80

 EPS

$5.18

Yield

164.32%

 Dividend

$0.51

EX-DIVIDEND DATE

Jan 2, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

2.48M

  

CAH Performance

1 Week
 
 0.19%
 
1 Month
 
 5.46%
 
3 Months
 
 9.57%
 
1 Year
 
 14.29%
 
5 Years
 
 123.20%
 

CAH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 19
Full Ratings ➔

About cardinal health inc. - CAH

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

CAH At a Glance

Cardinal Health, Inc.
7000 Cardinal Place
Dublin, Ohio 43017
Phone 1-614-757-5000 Revenue 226.83B
Industry Medical Distributors Net Income 852.00M
Sector Distribution Services 2024 Sales Growth 10.645%
Fiscal Year-end 06 / 2025 Employees 48,900
View SEC Filings

CAH Valuation

P/E Current 23.799
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 28.504
Price to Sales Ratio 0.107
Price to Book Ratio N/A
Price to Cash Flow Ratio 6.455
Enterprise Value to EBITDA 8.649
Enterprise Value to Sales 0.109
Total Debt to Enterprise Value 0.227

CAH Efficiency

Revenue/Employee 4,638,568.507
Income Per Employee 17,423.313
Receivables Turnover 18.749
Total Asset Turnover 5.124

CAH Liquidity

Current Ratio 0.979
Quick Ratio 0.559
Cash Ratio 0.144

CAH Profitability

Gross Margin 3.154
Operating Margin 0.949
Pretax Margin 0.529
Net Margin 0.376
Return on Assets 1.925
Return on Equity N/A
Return on Total Capital 35.559
Return on Invested Capital 51.999

CAH Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 234.098
Total Debt to Total Assets 12.431
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 211.102
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cardinal Health Inc. - CAH

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
162.48B 181.36B 205.00B 226.83B
Sales Growth
+6.25% +11.62% +13.04% +10.65%
Cost of Goods Sold (COGS) incl D&A
156.12B 175.13B 198.40B 219.67B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
805.00M 723.00M 692.00M 710.00M
Depreciation
377.00M 412.00M 411.00M 446.00M
Amortization of Intangibles
428.00M 311.00M 281.00M 264.00M
COGS Growth
+6.52% +12.18% +13.29% +10.72%
Gross Income
6.36B 6.23B 6.60B 7.15B
Gross Income Growth
+0.19% -2.04% +5.96% +8.36%
Gross Profit Margin
+3.91% +3.44% +3.22% +3.15%
2021 2022 2023 2024 5-year trend
SG&A Expense
4.54B 4.56B 4.83B 5.00B
Research & Development
- - - -
-
Other SG&A
4.54B 4.56B 4.83B 5.00B
SGA Growth
-0.53% +0.31% +6.06% +3.46%
Other Operating Expense
- - - -
-
Unusual Expense
1.29B 2.30B 1.02B 933.00M
EBIT after Unusual Expense
529.00M (623.00M) 749.00M 1.22B
Non Operating Income/Expense
(24.00M) 26.00M (16.00M) 48.00M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
182.00M 172.00M 95.00M 67.00M
Interest Expense Growth
-23.53% -5.49% -44.77% -29.47%
Gross Interest Expense
182.00M 172.00M 95.00M 67.00M
Interest Capitalized
- - - -
-
Pretax Income
323.00M (769.00M) 638.00M 1.20B
Pretax Income Growth
+108.56% -338.08% +182.96% +88.24%
Pretax Margin
+0.20% -0.42% +0.31% +0.53%
Income Tax
(289.00M) 163.00M 376.00M 348.00M
Income Tax - Current - Domestic
(897.00M) 63.00M 323.00M 373.00M
Income Tax - Current - Foreign
112.00M 93.00M 84.00M 79.00M
Income Tax - Deferred - Domestic
511.00M 8.00M 5.00M (77.00M)
Income Tax - Deferred - Foreign
(15.00M) (1.00M) (36.00M) (27.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
612.00M (932.00M) 262.00M 853.00M
Minority Interest Expense
1.00M 1.00M 1.00M 1.00M
Net Income
611.00M (933.00M) 261.00M 852.00M
Net Income Growth
+116.53% -252.70% +127.97% +226.44%
Net Margin Growth
+0.38% -0.51% +0.13% +0.38%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
611.00M (933.00M) 261.00M 852.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
611.00M (933.00M) 261.00M 852.00M
EPS (Basic)
2.0925 -3.3441 1 3.4776
EPS (Basic) Growth
+116.59% -259.81% +129.90% +247.76%
Basic Shares Outstanding
292.00M 279.00M 261.00M 245.00M
EPS (Diluted)
2.0782 -3.3441 0.9962 3.4494
EPS (Diluted) Growth
+116.47% -260.91% +129.79% +246.26%
Diluted Shares Outstanding
294.00M 279.00M 262.00M 247.00M
EBITDA
2.62B 2.40B 2.46B 2.86B
EBITDA Growth
-2.82% -8.62% +2.67% +16.38%
EBITDA Margin
+1.61% +1.32% +1.20% +1.26%

Snapshot

Average Recommendation HOLD Average Target Price 127.857
Number of Ratings 19 Current Quarters Estimate 1.759
FY Report Date 12 / 2024 Current Year's Estimate 7.801
Last Quarter’s Earnings 1.88 Median PE on CY Estimate N/A
Year Ago Earnings 7.53 Next Fiscal Year Estimate 8.658
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 16 15
Mean Estimate 1.76 2.19 7.80 8.66
High Estimates 1.88 2.25 7.95 8.99
Low Estimate 1.46 2.06 7.60 8.25
Coefficient of Variance 5.46 2.85 1.21 2.27

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 2 2 3
HOLD 10 10 9
UNDERWEIGHT 1 1 1
SELL 1 1 1
MEAN Hold Hold Overweight

Insider Actions for Cardinal Health Inc. - CAH

Date Name Shares Transaction Value
Nov 8, 2024 Robert W. Azelby Director 3,018 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 8, 2024 Michelle M. Brennan Director 7,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 8, 2024 Christine Ann Mundkur Director 6,469 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 8, 2024 Nancy Killefer Director 26,557 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 8, 2024 Sheri H. Edison Director 13,781 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 8, 2024 David C. Evans Director 14,306 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 8, 2024 Akhil Johri Director 21,801 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 8, 2024 Gregory B. Kenny Director 62,492 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 8, 2024 Patricia A. Hemingway Hall Director 31,197 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Aaron E. Alt Chief Financial Officer 36,867 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $108.91 per share 4,015,184.97
Aug 20, 2024 Aaron E. Alt Chief Financial Officer 39,190 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $107.91 per share 4,228,992.90
Aug 20, 2024 Aaron E. Alt Chief Financial Officer 41,671 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Jessica L. Mayer Chief Legal/Compliance Officer 92,261 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $106.36 per share 9,812,879.96
Aug 20, 2024 Jessica L. Mayer Chief Legal/Compliance Officer 103,752 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 20, 2024 Jessica L. Mayer Chief Legal/Compliance Officer 106,891 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $83.91 per share 8,969,223.81
Aug 20, 2024 Jessica L. Mayer Chief Legal/Compliance Officer 112,425 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $66.43 per share 7,468,392.75
Aug 20, 2024 Jessica L. Mayer Chief Legal/Compliance Officer 94,529 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $106.48 per share 10,065,447.92
Aug 20, 2024 Jessica L. Mayer Chief Legal/Compliance Officer 92,544 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $107.91 per share 9,986,423.04
Aug 20, 2024 Jessica L. Mayer Chief Legal/Compliance Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 20, 2024 Jessica L. Mayer Chief Legal/Compliance Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Cardinal Health Inc. in the News